Am J Psychiatry 161:692-699, April 2004
© 2004 American Psychiatric Association
Adherence to Treatment With Antipsychotic Medication and Health Care Costs Among Medicaid Beneficiaries With Schizophrenia
Todd P. Gilmer, Ph.D.,
Christian R. Dolder, Pharm.D.,
Jonathan P. Lacro, Pharm.D.,
David P. Folsom, M.D.,
Laurie Lindamer, Ph.D.,
Piedad Garcia, Ed.D., and
Dilip V. Jeste, M.D.
OBJECTIVE: The authors’ goal was to evaluate the relationship between adherence to treatment with antipsychotic medication and health expenditures. A secondary objective was to identify risk factors predictive of nonadherence. METHOD: Data included Medicaid eligibility and claims data from 1998 to 2000 for San Diego County, Calif. Pharmacy records were used to assess adherence to treatment with antipsychotic medication according to the cumulative possession ratio (the number of days medications were available for consumption divided by the number of days subjects were eligible for Medi-Cal). Regression models were used to examine risk factors, hospitalizations, and costs associated with nonadherence, partial adherence, adherence, and excess fills of antipsychotic medication. RESULTS: Forty-one percent of Medicaid beneficiaries with schizophrenia were found to be adherent to treatment with their antipsychotic medications: 24% were nonadherent, 16% were partially adherent, and 19% were excess fillers. Rates of psychiatric hospitalization were lower for those who were adherent (14%) than for those who were nonadherent (35%), partially adherent (24%), or had excess fills (25%). Rates of medical hospitalization were lower for those who were adherent (7%) than for those who were nonadherent (13%) or had excess fills (12%). Those who were adherent had significantly lower hospital costs than the other groups; pharmacy costs were higher among those who were adherent than among those who were nonadherent or partially adherent and were highest for excess fillers. Total costs for excess fillers ($14,044) were substantially higher than total costs for any other group. CONCLUSIONS: Despite the widespread use of atypical antipsychotic medications, alarmingly high rates of both underuse and excessive filling of antipsychotic prescriptions were found in Medicaid beneficiaries with schizophrenia. The high rates of antipsychotic nonadherence and associated negative consequences suggest interventions on multiple levels.
Related Article:
-
In This Issue
Am J Psychiatry 2004 161: A80.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
L. R. Snowden, J. F. Hastings, and J. Alvidrez
Overrepresentation of Black Americans in Psychiatric Inpatient Care
Psychiatr Serv,
June 1, 2009;
60(6):
779 - 785.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C. West, J. E. Wilk, D. S. Rae, I. S. Muszynski, M. R. Stipec, C. L. Alter, K. E. Sanders, S. Crystal, and D. A. Regier
Medicaid Prescription Drug Policies and Medication Access and Continuity: Findings From Ten States
Psychiatr Serv,
May 1, 2009;
60(5):
601 - 610.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. E. Smith and L. I. Sederer
A New Kind of Homelessness for Individuals With Serious Mental Illness? The Need for a "Mental Health Home"
Psychiatr Serv,
April 1, 2009;
60(4):
528 - 533.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. M. Lanouette, D. P. Folsom, A. Sciolla, and D. V. Jeste
Psychotropic Medication Nonadherence Among United States Latinos: A Comprehensive Literature Review
Psychiatr Serv,
February 1, 2009;
60(2):
157 - 174.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. P. Gilmer, V. D. Ojeda, C. Barrio, D. Fuentes, P. Garcia, N. M. Lanouette, and K. C. Lee
Adherence to Antipsychotics Among Latinos and Asians With Schizophrenia and Limited English Proficiency
Psychiatr Serv,
February 1, 2009;
60(2):
175 - 182.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Olfson, S. C. Marcus, and G. J. Wan
Treatment Patterns for Schizoaffective Disorder and Schizophrenia Among Medicaid Patients
Psychiatr Serv,
February 1, 2009;
60(2):
210 - 216.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. C Martin, E. K Wiley-Exley, S. Richards, M. E Domino, T. S Carey, and B. L. Sleath
Contrasting Measures of Adherence with Simple Drug Use, Medication Switching, and Therapeutic Duplication
Ann. Pharmacother.,
January 1, 2009;
43(1):
36 - 44.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Faught, M. S. Duh, J. R. Weiner, A. Guerin, and M. C. Cunnington
Nonadherence to antiepileptic drugs and increased mortality: Findings from the RANSOM Study
Neurology,
November 11, 2008;
71(20):
1572 - 1578.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Depp, V. D. Ojeda, W. Mastin, J. Unutzer, and T. P. Gilmer
Trends in Use of Antipsychotics and Mood Stabilizers Among Medicaid Beneficiaries With Bipolar Disorder, 2001-2004
Psychiatr Serv,
October 1, 2008;
59(10):
1169 - 1174.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. N. Pfeiffer, D. Ganoczy, and M. Valenstein
Dosing Frequency and Adherence to Antipsychotic Medications
Psychiatr Serv,
October 1, 2008;
59(10):
1207 - 1210.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Stafford, H. J. Jackson, and M. Berk
Illness Beliefs About Heart Disease and Adherence to Secondary Prevention Regimens
Psychosom Med,
October 1, 2008;
70(8):
942 - 948.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Kreyenbuhl, L. B. Dixon, J. F. McCarthy, S. Soliman, R. V. Ignacio, and M. Valenstein
Does Adherence to Medications for Type 2 Diabetes Differ Between Individuals With Vs Without Schizophrenia?
Schizophr Bull,
August 20, 2008;
(2008)
sbn106v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. R. Law, D. Ross-Degnan, and S. B. Soumerai
Effect of Prior Authorization of Second-Generation Antipsychotic Agents on Pharmacy Utilization and Reimbursements
Psychiatr Serv,
May 1, 2008;
59(5):
540 - 546.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. I. Velligan, P. M. Diamond, J. Mintz, N. Maples, X. Li, J. Zeber, L. Ereshefsky, Y.-W. F. Lam, D. Castillo, and A. L. Miller
The Use of Individually Tailored Environmental Supports to Improve Medication Adherence and Outcomes in Schizophrenia
Schizophr Bull,
May 1, 2008;
34(3):
483 - 493.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. C. Marcus and M. Olfson
Outpatient Antipsychotic Treatment and Inpatient Costs of Schizophrenia
Schizophr Bull,
January 1, 2008;
34(1):
173 - 180.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. P. Gilmer, V. D. Ojeda, D. P. Folsom, D. Fuentes, P. Garcia, and D. V. Jeste
Initiation and Use of Public Mental Health Services by Persons With Severe Mental Illness and Limited English Proficiency
Psychiatr Serv,
December 1, 2007;
58(12):
1555 - 1562.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Olfson, S. C. Marcus, and H. Ascher-Svanum
Treatment of Schizophrenia With Long-Acting Fluphenazine, Haloperidol, or Risperidone
Schizophr Bull,
November 1, 2007;
33(6):
1379 - 1387.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E. Hovens and A. J. M. Loonen
Adding and Switching Antipsychotics
Psychiatr Serv,
October 1, 2007;
58(10):
1375 - 1375.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. I. Velligan, M. Wang, P. Diamond, D. C. Glahn, D. Castillo, S. Bendle, Y. W. F. Lam, L. Ereshefsky, and A. L. Miller
Relationships Among Subjective and Objective Measures of Adherence to Oral Antipsychotic Medications
Psychiatr Serv,
September 1, 2007;
58(9):
1187 - 1192.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Mitchell and T. Selmes
Why don't patients take their medicine? Reasons and solutions in psychiatry
Advan. Psychiatr. Treat.,
September 1, 2007;
13(5):
336 - 346.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. P. Folsom, T. Gilmer, C. Barrio, D. J. Moore, J. Bucardo, L. A. Lindamer, P. Garcia, W. Hawthorne, R. Hough, T. Patterson, et al.
A Longitudinal Study of the Use of Mental Health Services by Persons With Serious Mental Illness: Do Spanish-Speaking Latinos Differ From English-Speaking Latinos and Caucasians?
Am J Psychiatry,
August 1, 2007;
164(8):
1173 - 1180.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. A. KEKS, M. INGHAM, A. KHAN, and K. KARCHER
Long-acting injectable risperidone v. olanzapine tablets for schizophrenia or schizoaffective disorder: Randomised, controlled, open-label study
The British Journal of Psychiatry,
August 1, 2007;
191(2):
131 - 139.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. P. Gilmer, C. R. Dolder, D. P. Folsom, W. Mastin, and D. V. Jeste
Antipsychotic Polypharmacy Trends Among Medi-Cal Beneficiaries With Schizophrenia in San Diego County, 1999-2004
Psychiatr Serv,
July 1, 2007;
58(7):
1007 - 1010.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Sajatovic, M. Valenstein, F. Blow, D. Ganoczy, and R. Ignacio
Treatment Adherence With Lithium and Anticonvulsant Medications Among Patients With Bipolar Disorder
Psychiatr Serv,
June 1, 2007;
58(6):
855 - 863.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. M. Woltmann, M. Valenstein, D. E. Welsh, T. A. Lee, P. A. Wolschon, J. Grabowski, and P. A. Reilly
Using Pharmacy Data on Partial Adherence to Inform Clinical Care of Patients With Serious Mental Illness
Psychiatr Serv,
June 1, 2007;
58(6):
864 - 867.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Shi, H. Ascher-Svanum, B. Zhu, D. Faries, W. Montgomery, and S. R. Marder
Characteristics and Use Patterns of Patients Taking First-Generation Depot Antipsychotics or Oral Antipsychotics for Schizophrenia
Psychiatr Serv,
April 1, 2007;
58(4):
482 - 488.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. D. Piette, M. Heisler, D. Ganoczy, J. F. McCarthy, and M. Valenstein
Differential Medication Adherence Among Patients With Schizophrenia and Comorbid Diabetes and Hypertension
Psychiatr Serv,
February 1, 2007;
58(2):
207 - 212.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. L Bettinger, G. Shuler, D. R Jones, and J. P Wilson
Schizophrenia: Multi-Attribute Utility Theory Approach to Selection of Atypical Antipsychotics
Ann. Pharmacother.,
February 1, 2007;
41(2):
201 - 207.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. C. Singh, A. J. Massey, M. D. Thompson, L. R. Rappa, and M. S. Honeywell
Addressing Nonadherence in the Schizophrenic Population
Journal of Pharmacy Practice,
December 1, 2006;
19(6):
361 - 368.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. G. Katz, S. Kripalani, and B. D. Weiss
Use of pictorial aids in medication instructions: A review of the literature
Am. J. Health Syst. Pharm.,
December 1, 2006;
63(23):
2391 - 2397.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. I. Velligan, Y.-W. F. Lam, D. C. Glahn, J. A. Barrett, N. J. Maples, L. Ereshefsky, and A. L. Miller
Defining and Assessing Adherence to Oral Antipsychotics: A Review of the Literature
Schizophr Bull,
October 1, 2006;
32(4):
724 - 742.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Kissling, S. Heres, K. Lloyd, E. Sacchetti, P. Bouhours, R. Medori, and P. M. Llorca
Direct transition to long-acting risperidone - analysis of long-term efficacy
J Psychopharmacol,
September 1, 2005;
19(5_suppl):
15 - 21.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Mohl, K. Westlye, S. Opjordsmoen, A. Lex, A. Schreiner, M. Benoit, P. Braunig, and R. Medori
Long-acting risperidone in stable patients with schizoaffective disorder
J Psychopharmacol,
September 1, 2005;
19(5_suppl):
22 - 31.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. R. Recker, R. Gallagher, and P. E. MacCosbe
Effect of Dosing Frequency on Bisphosphonate Medication Adherence in a Large Longitudinal Cohort of Women
Mayo Clin. Proc.,
July 1, 2005;
80(7):
856 - 861.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. M. Gardner, R. J. Baldessarini, and P. Waraich
Modern antipsychotic drugs: a critical overview
Can. Med. Assoc. J.,
June 21, 2005;
172(13):
1703 - 1711.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. P. Folsom, W. Hawthorne, L. Lindamer, T. Gilmer, A. Bailey, S. Golshan, P. Garcia, J. Unutzer, R. Hough, and D. V. Jeste
Prevalence and Risk Factors for Homelessness and Utilization of Mental Health Services Among 10,340 Patients With Serious Mental Illness in a Large Public Mental Health System
Am J Psychiatry,
February 1, 2005;
162(2):
370 - 376.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. J. Weiden, C. Kozma, A. Grogg, and J. Locklear
Partial Compliance and Risk of Rehospitalization Among California Medicaid Patients With Schizophrenia
Psychiatr Serv,
August 1, 2004;
55(8):
886 - 891.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Rosack
Education on Medication Adherence Will Reduce Costs, Improve Outcome
Psychiatr News,
May 7, 2004;
39(9):
20 - 21.
[Full Text]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2004
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
